Ostrum Asset Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96M Buy
27,708
+7,093
+34% +$531K 0.11% 146
2025
Q4
$1.63M Sell
20,615
-2,554
-11% -$202K 0.08% 196
2025
Q3
$1.91M Sell
23,169
-6,621
-22% -$521K 0.09% 200
2025
Q2
$2.4M Sell
29,790
-69
-0.2% -$5.33K 0.11% 174
2025
Q1
$2.4M Buy
29,859
+595
+2% +$49.5K 0.13% 160
2024
Q4
$2.4M Sell
29,264
-1,124
-4% -$93.5K 0.21% 156
2024
Q3
$2.51M Sell
30,388
-1,632
-5% -$122K 0.21% 170
2024
Q2
$2.25M Sell
32,020
-1,746
-5% -$125K 0.2% 177
2024
Q1
$2.5M Sell
33,766
-5,701
-14% -$397K 0.2% 181
2023
Q4
$2.61M Sell
39,467
-6,257
-14% -$392K 0.23% 142
2023
Q3
$2.88M Buy
45,724
+1,658
+4% +$103K 0.27% 108
2023
Q2
$2.49M Sell
44,066
-991
-2% -$55K 0.21% 161
2023
Q1
$2.61M Buy
+45,057
New +$3.04M 0.23% 152

Other funds holding MET

Ostrum Asset Management's MET Position: Q1 2026 in Review

Ostrum Asset Management increased its MetLife (MET) stake by 34% in Q1 2026, buying an estimated $531K and bringing the position to 27,708 shares worth $1.96M. The position accounts for 0.11% of the portfolio, ranked #146.

Ostrum Asset Management first reported a position in MET in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.88M in Q3 2023. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Ostrum Asset Management held 27,708 shares of MetLife worth $1.96M as of Q1 2026.
  • Ostrum Asset Management bought 7,093 MetLife shares in Q1 2026, an estimated $531K.
  • MetLife made up 0.11% of Ostrum Asset Management's portfolio in Q1 2026, its #146 holding.
  • Ostrum Asset Management first reported a position in MetLife in Q1 2023 and has held it in 13 quarters since.
  • Ostrum Asset Management's MetLife position peaked at $2.88M in Q3 2023.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.